Skip to content
healthcare.dev

Risedronate Sodium

NDC 60723-041, Risedronate Sodium, tablet, film coated, from Hangzhou Minsheng Binjiang Pharmaceutical CO., Ltd.

Product NDC
60723-041
Status
Listed
Labeler
Hangzhou Minsheng Binjiang Pharmaceutical CO., Ltd
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA207516
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/60723-041 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RISEDRONATE SODIUM HEMI-PENTAHYDRATE35 mg/1

Pharmacologic classes

Bisphosphonate [EPC]; Diphosphonates [CS]

Package NDCNDC-11Package
60723-041-04607230041041 BLISTER PACK in 1 CARTON (60723-041-04) / 4 TABLET, FILM COATED in 1 BLISTER PACK (60723-041-01)
60723-041-12607230041123 BLISTER PACK in 1 CARTON (60723-041-12) / 4 TABLET, FILM COATED in 1 BLISTER PACK (60723-041-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d60a56cb-ef49-4447-9043-7b6879a20d75

Use it

Look up 60723-041 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/60723-041 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 60723-041. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.